Flyover HealthTech: Rehabbing stroke patients; cancer testing; reducing infections
- Neurolutions’ IpsiHand System, a Brain-Computer-Interface (BCI) device that assists in rehabilitation for stroke patients with upper extremity disability, has received FDA approval.
- University of Cincinnati researchers are looking at the connection between a protein found in skeletal muscle fiber and the body’s fight or fight response during stress.
- A clinical trial at The Ohio State University is using gene therapy in a new approach to help those suffering from chronic angina who can’t undergo stenting or coronary bypass surgery.
- Amplified Sciences, a diagnostic cancer testing startup that uses technology created by a Purdue University professor, has received investments from the IU Philanthropic Venture Fund the IU Angel Network.
- Catheter-associated urinary tract infections (CAUTIs) are the second most common healthcare-associated infection in ICUs. A nurse-driven quality improvement at UPMC Williamsport has cut CAUTI rates.
- Indy-based Eli Lilly is seeking first approval of an autoimmune drug for hair loss. The drug, baricitinib, spurred hair regrowth in patients with a severe form of alopecia areata in a second Phase 3 study.